openPR Logo
Press release

Mono Vaccine Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

09-05-2018 01:45 PM CET | Health & Medicine

Press release from: Vaccination Training

Mono Vaccine Market - Global Industry Insights, Trends,

Worldwide Market Reports added Latest Research Report titled "Mono Vaccine Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026" to its Large Report database.

Mononucleosis (mono) also called as glandular fever is infectious disease caused by Epstein-Barr virus (EBV), which can be transmitted through saliva, exposure to cough or sneeze, and by sharing a glass or food utensils with person suffering from mono. This infection is characterized by various symptoms such as fatigue, sore throat, fever, swollen lymph nodes in neck and armpits, swollen tonsils, headache, and skin rash. Although, there is no specific treatment option is avaible for this disease, consumption of adequate amount of nutrition and fluid can help in improving diseased condition.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/147128

Increasing prevalence of infectious disease and lack of availability for treatment option are major factors driving growth of the mono vaccine market. According to the National Institute of Environmental Health Sciences, autoimmune diseases affects more than 23.5 million Americans annually. Research studies have reported link between EBV infection and high risk of developing autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus. For instance, in April 2018, researchers at Cincinnati Children’s Hospital Medical Center reported that a protein synthesized by the Epstein-Barr virus binds to areas of the human genome linked to an increased risk of certain diseases such as multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, inflammatory bowel disease, celiac disease, and Type 1 diabetes. However, high cost of research and development and long period for reaching the end-product to market due to various tests and clinical trial are major factors restraining growth of the mono vaccine market.

Request for Discount @ https://www.worldwidemarketreports.com/discount/147128

Key Developments of Mono Vaccine Market

Several research organizations are working on developing vaccine or treatment for prevention of EBV infections. In April 2018, researchers from Fred Hutchinson Cancer Research Center and the University of Washington discovered human antibody that can block EBV infection. Discovery of new antibody along with its target site is creating new opportunities for development of effective vaccine against EBV virus. Furthermore, in 2017, University of Kansas School of Engineering and School of Pharmacy conducted study to analyze the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against EBV. Manufacturers are majorly investing in research and development for introducing effective vaccine against EBV infection. Major players operating in mono vaccine market include CNBG, Serum Institute of India, Biokangtai, Merck, Pfizer, GSK, and Sanofi Pasteur

Request for Table of Content :https://www.worldwidemarketreports.com/toc/147128

** If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email:sales@worldwidemarketreports.com
Visit our website for more details:https://www.worldwidemarketreports.com
Visit our new website for latest News:https://www.industrychronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mono Vaccine Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 here

News-ID: 1221896 • Views:

More Releases from Vaccination Training

Safe Patient Moving Techniques Can Now Be Learned At ECG
(Milton Keynes, UK) - ECG (ecgtraining.co.uk) is proud to inform all interested medical practitioners of the availability of their Moving and Handling courses. At present, this reputable medical training provider offers three onsite instructions: Patient Handling, Safer Handling (Loads), and Safer Handling for GP and Dental Practices. These courses are particularly beneficial for those whose daily responsibilities include repositioning patients while ensuring their safety the entire time. ECG can conduct these

More Releases for EBV

Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease …
Introduction Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) is a rare but potentially life-threatening complication arising in patients who undergo solid organ or hematopoietic stem cell transplants. Triggered by immunosuppression, PTLD represents a spectrum of lymphoid proliferations ranging from benign polyclonal hyperplasia to aggressive lymphomas. While rare, it remains one of the most serious complications of transplantation, significantly affecting survival rates and long-term outcomes. Over the past decade, advances in immunotherapy, diagnostics,
Epstein-Barr Virus (EBV) Market Growth, Applications, Innovations and Business O …
Introduction The Epstein-Barr Virus (EBV), a member of the herpesvirus family, is one of the most common human viruses. It infects over 90% of the global population, often during childhood or adolescence, and remains dormant in the body for life. EBV is best known as the cause of infectious mononucleosis ("mono"), but it has also been linked to more serious conditions, including Hodgkin's lymphoma, Burkitt's lymphoma, gastric cancer, nasopharyngeal carcinoma, and
Epstein-Barr Virus (EBV) Market Generated Opportunities, Future Scope 2025-2032 …
The latest report on the "Epstein-Barr Virus (EBV) Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors
Epstein-Barr Virus (EBV) Market Generated Opportunities, Future Scope 2025-2032 …
The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.48 Billion in 2025 and is expected to reach USD 2.18 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. The Latest published market study on Epstein-Barr Virus (EBV) Market report provides an overview of the current market dynamics as well as what our survey respondents- all outsourcing decision-makers- predict the
Epstein-Barr Virus (EBV) Market Growth 2025: Trends, Consumer Demand, and Key Op …
The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.53% from 2024 to 2031. According to the latest research from CoherentMI, the Epstein-Barr Virus (EBV) Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based
Epstein-Barr Virus (EBV) Market Sector Size, Growth Trends, and Share Analysis R …
A new Report by CoherentMI Market Reports, titled "Epstein-Barr Virus (EBV) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Epstein-Barr Virus (EBV) market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected